BridgeBio Pharma, Inc. (BBIO)

76.53 +0.13 (+0.17%) USD  |  NASDAQ  |  Dec 24, 16:00
More

BridgeBio Pharma Cash and Short Term Investments (Annual): 681.23M for Dec. 31, 2024

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Pfizer Inc. 20.48B
Alnylam Pharmaceuticals, Inc. 2.695B
Supernus Pharmaceuticals, Inc. 453.61M
Ionis Pharmaceuticals, Inc. 2.303B
Regeneron Pharmaceuticals, Inc. 9.012B